Literature DB >> 15562889

Role of 90K protein in asthma and TH2-type cytokine expression.

Omer Kalayci1, Esra Birben, Nicola Tinari, Tsuyoshi Oguma, Stefano Iacobelli, Craig M Lilly.   

Abstract

BACKGROUND: The 90K protein (mac-2 binding protein) is a member of the macrophage scavenger receptor cysteine-rich domain superfamily. Although systemic levels of 90K protein have been correlated with inflammation in many diseases, its role in asthma is unknown.
OBJECTIVE: To determine whether asthma is associated with changes in the local and systemic expression of 90K protein and whether 90K protein affects the TH2 cytokine profile that is a hallmark of asthma.
METHODS: The 90K protein levels were measured in the systemic circulation of 69 individuals with asthma and 68 controls and in the bronchoalveolar lavage fluid of 9 controls and 7 atopic asthmatic patients before and after segmental allergen challenge. The effects of 90K protein on interleukin 4 (IL-4), IL-5, IL-13, and IL-6 production at protein and transcriptional levels in cultured human peripheral blood mononuclear cells were determined.
RESULTS: Plasma concentrations of 90K protein were higher in asthmatic individuals vs controls (P = .002), were higher in the bronchoalveolar lavage fluid of asthmatic patients vs controls (P < .01), and increased after segmental allergen challenge in atopic asthmatic patients (P < .03). Increasing concentrations of 90K protein resulted in significantly reduced IL-4, IL-5, and IL-13 concentrations and increased IL-6 concentrations in the supernatants of cultured peripheral blood mononuclear cells (P < .05). Reverse transcriptase-polymerase chain reaction studies showed parallel changes in the transcription of these cytokines.
CONCLUSIONS: Local and systemic concentrations of 90K protein are increased in asthma. Its inhibitory effect on TH2 cytokine transcription suggests that increased 90K protein expression is an attempt to limit the ongoing inflammation in asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15562889     DOI: 10.1016/S1081-1206(10)61417-2

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  8 in total

1.  A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.

Authors:  Ayaka M Silverman; Rie Nakata; Hiroyuki Shimada; Richard Sposto; Yves A DeClerck
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

Review 2.  Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Valentina Gallo; Alyexandra Arienzo; Stefano Iacobelli; Valentina Iacobelli; Giovanni Antonini
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

3.  Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1.

Authors:  Chang-Soo Hong; Mi-Ra Park; Eun-Gene Sun; Wonyoung Choi; Jun-Eul Hwang; Woo-Kyun Bae; Joon Haeng Rhee; Sang-Hee Cho; Ik-Joo Chung
Journal:  Front Immunol       Date:  2019-07-26       Impact factor: 7.561

4.  Comparative two time-point proteome analysis of the plasma from preterm infants with and without bronchopulmonary dysplasia.

Authors:  Magdalena Zasada; Maciej Suski; Renata Bokiniec; Monika Szwarc-Duma; Maria Katarzyna Borszewska-Kornacka; Józef Madej; Beata Bujak-Giżycka; Anna Madetko-Talowska; Cecilie Revhaug; Lars O Baumbusch; Ola D Saugstad; Jacek Józef Pietrzyk; Przemko Kwinta
Journal:  Ital J Pediatr       Date:  2019-08-24       Impact factor: 2.638

5.  Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex.

Authors:  Gang Xu; Zhangchuan Xia; Feiyan Deng; Lin Liu; Qiming Wang; Yi Yu; Fubing Wang; Chengliang Zhu; Weiyong Liu; Zhikui Cheng; Ying Zhu; Li Zhou; Yi Zhang; Mengji Lu; Shi Liu
Journal:  PLoS Pathog       Date:  2019-08-12       Impact factor: 6.823

6.  Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling.

Authors:  Sang-Hee Cho; Hyun-Jeong Shim; Mi-Ra Park; Ji-Na Choi; Md Rashedunnabi Akanda; Jun-Eul Hwang; Woo-Kyun Bae; Kyung-Hwa Lee; Eun-Gene Sun; Ik-Joo Chung
Journal:  Cell Death Discov       Date:  2021-04-06

7.  Value of M2BP in predicting in-stent restenosis in patients after coronary drug-eluting stent implantation.

Authors:  Le Yang; Haijun Zhu; Yuanyuan Sun; Pengcheng Yan; Xiaoning Song; Fayun Xu; Haitao Yuan; Liming Chen
Journal:  Clin Cardiol       Date:  2022-01-15       Impact factor: 2.882

8.  Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma.

Authors:  Apeng Chen; Yinan Jiang; Zhengwei Li; Lingxiang Wu; Ulises Santiago; Han Zou; Chunhui Cai; Vaibhav Sharma; Yongchang Guan; Lauren H McCarl; Jie Ma; Yijen L Wu; Joshua Michel; Yi Shi; Liza Konnikova; Nduka M Amankulor; Pascal O Zinn; Gary Kohanbash; Sameer Agnihotri; Songjian Lu; Xinghua Lu; Dandan Sun; George K Gittes; Qianghu Wang; Xiangwei Xiao; Dean Yimlamai; Ian F Pollack; Carlos J Camacho; Baoli Hu
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.